Ant Group's AQ Ranks 7th in China's AI App List: The Only Health-Focused App in Top 10

Deep News
Oct 28

On October 28, QuestMobile released its "2025 Q3 AI Application Industry Report," listing Doubao, DeepSeek, Yuanbao, and AQ among China's top 10 AI-native applications. Notably, Ant Group's AI health app AQ climbed three spots in just one month to rank seventh, only three months after its standalone app launch.

AQ stands out as the only health-focused application in China's top 10 AI-native apps, even surpassing general AI products like Tongyi and Wenxiaoyan in user scale. The report highlights AQ's remarkable 83.4% compound growth rate in Q3, far exceeding the industry average of 13.5%, making it the fastest-growing dark horse in China's 2025 AI application market.

Ant Group is also accelerating the integration of Haodf.com with its health services. Recently, Haodf officially joined Alipay's medical and health channel, collaborating with AQ to launch new services like "AI Doctor Finder." Users can now access smart triage, expert matching, and appointment booking in one place. By clicking "AI Doctor Finder" in Alipay's health channel and entering their query, AQ intelligently recommends doctors from Haodf's platform, enabling quick consultations or bookings.

In recent years, Ant Group has intensified its healthcare investments, elevating AI-driven medical health to a strategic priority. During September's Bund Summit, Ant Group CEO Han Xinyi emphasized the irreplaceable role of specialized AI in healthcare, stating that Ant will focus on AI applications to bring smart technology into daily life.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10